How 'bout a little R & R ?
RecoveryRx & Reimbursement
The generally accepted consensus is that the share price is driven by sales, revenue, and profit. No argument here. What motivates this is exposure of the good product, placement of said product, retail shelves, media buzz with a heavy dose of non-stop marketing. The quarterlys come out and everybody's happy. Having multiple OEM partners turbocharges that paradigm. Still, it's basically the same.
While not disputing the obviousness of that, I would maintain that the primary driver of explosive growth (in the share price) is a mass of investors wanting a 'piece of the action', is Reimbursement. FOMO (fear of missing out) is a strong motivator. Having the customer understand that getting the product (and, so, relieving pain) is super easy b/c it is paid for by the insurance; either private, VA, Medicare/aid, HMO/PPO, etc., is a huge growth driver, even more than widespread retail in multiple chains, imo. You get the product as a result of making your insurance payment, not as a separate purchase in addition to paying the insurance premium. More bang for your buck.
Ask yourself this. How many times have you, or someone close to you, debated whether to buy this or that, get a procedure done, and whether or not it is 'covered' was a big part of the conversation? The same is true on the other end. Medical personnel are more than willing to prescribe a treatment knowing it is not coming out of the patient's pocket. Moreso, the doctor knows the payment is guaranteed. Retail is good, the more the better, but Reimbursement is a whole 'nuther ballgame.
Getting on an insurance Reimbursement schedule is a quantum leap forward. We're playing in the big leagues now and accomplishing this would attract the big investors (the much rumored Whales). Signing an agreement of this magnitude virtually guarantees very significant revenues for the foreseeable future and big investors salivate over predictable profits in a fast-growing industry such as drug-free pain relief. If billion dollar enterprises trust our product can Insurance Reimbursement be the next big thing for us?
I don't know if the phrase 'Standard of Care' has significant, legally-binding meaning in insurance contracts. We are all aware (painfully so) of the most recent, and ongoing, silence from the company. I'm taking a 'Run Silent, Run Deep' approach to it. That is to say, I am of the belief that RecoveryRx has made such an impact on the medical community-at-large, it has brought a bunch of very interested parties to the table for a serious pow-wow. Generally speaking, I think we are a serious player at the table.
For me, the share price, is a non-issue and a temporary one. Ihub poster 'The Pro', post #262742, has the 5 yr. 'cup & handle' chart and it is worth looking at. From a high of 0.008 we have regressed over 50% so it is definitely ready for a major move upwards. With all that can, and probably will, happen (or be revealed and/or announced) over the next 90 days, that move could propel us into pennyland, possibly beyond. Sure, take some profits. A modest appreciation of technical trading can be very profitable. After all, grocerys don't accept stock charts as payment.
At first, it was let's get these sales reps hitting the streets, sign customers up and ... on your mark, get set, GO!!! Somewhere along the way, somebody in authority got hold of the actual data, read it carefully, and then called his buddy to confirm what he's thinking. Made some more calls which led him to 'discover' the NHS study. Save tons of money whilst improving the outcomes, lowers insurance costs due to better outcomes, reduced exposure to lawsuits, reduced hospital costs, patient satisfaction, etc. Next thing you know, the phone is ringing for Keith and Kelly.
You don't have to remind me of the guesswork inherent in this post. I get it. I also get the Actipatch PEMF tech, KT Tape (smart, aggressive marketing; recent signing of tennis #1 ranked player Sofia Kenin; the Olympics), DJO, unannounced SAI, Allay, migraine studies, the ever elusive Dr. Scholl's and probably a whole lot more I'm not mentioning. Something very mysterious happening at the FDA with another possible OEM and/or licensing? I know, FDA and mysterious in the same sentence, will wonders ever cease?
Bright future, lots of positive energy.
Remember to eat your vegetables, kids - WBeacham
RecoveryRx & Reimbursement
The generally accepted consensus is that the share price is driven by sales, revenue, and profit. No argument here. What motivates this is exposure of the good product, placement of said product, retail shelves, media buzz with a heavy dose of non-stop marketing. The quarterlys come out and everybody's happy. Having multiple OEM partners turbocharges that paradigm. Still, it's basically the same.
While not disputing the obviousness of that, I would maintain that the primary driver of explosive growth (in the share price) is a mass of investors wanting a 'piece of the action', is Reimbursement. FOMO (fear of missing out) is a strong motivator. Having the customer understand that getting the product (and, so, relieving pain) is super easy b/c it is paid for by the insurance; either private, VA, Medicare/aid, HMO/PPO, etc., is a huge growth driver, even more than widespread retail in multiple chains, imo. You get the product as a result of making your insurance payment, not as a separate purchase in addition to paying the insurance premium. More bang for your buck.
Ask yourself this. How many times have you, or someone close to you, debated whether to buy this or that, get a procedure done, and whether or not it is 'covered' was a big part of the conversation? The same is true on the other end. Medical personnel are more than willing to prescribe a treatment knowing it is not coming out of the patient's pocket. Moreso, the doctor knows the payment is guaranteed. Retail is good, the more the better, but Reimbursement is a whole 'nuther ballgame.
Getting on an insurance Reimbursement schedule is a quantum leap forward. We're playing in the big leagues now and accomplishing this would attract the big investors (the much rumored Whales). Signing an agreement of this magnitude virtually guarantees very significant revenues for the foreseeable future and big investors salivate over predictable profits in a fast-growing industry such as drug-free pain relief. If billion dollar enterprises trust our product can Insurance Reimbursement be the next big thing for us?
I don't know if the phrase 'Standard of Care' has significant, legally-binding meaning in insurance contracts. We are all aware (painfully so) of the most recent, and ongoing, silence from the company. I'm taking a 'Run Silent, Run Deep' approach to it. That is to say, I am of the belief that RecoveryRx has made such an impact on the medical community-at-large, it has brought a bunch of very interested parties to the table for a serious pow-wow. Generally speaking, I think we are a serious player at the table.
For me, the share price, is a non-issue and a temporary one. Ihub poster 'The Pro', post #262742, has the 5 yr. 'cup & handle' chart and it is worth looking at. From a high of 0.008 we have regressed over 50% so it is definitely ready for a major move upwards. With all that can, and probably will, happen (or be revealed and/or announced) over the next 90 days, that move could propel us into pennyland, possibly beyond. Sure, take some profits. A modest appreciation of technical trading can be very profitable. After all, grocerys don't accept stock charts as payment.
At first, it was let's get these sales reps hitting the streets, sign customers up and ... on your mark, get set, GO!!! Somewhere along the way, somebody in authority got hold of the actual data, read it carefully, and then called his buddy to confirm what he's thinking. Made some more calls which led him to 'discover' the NHS study. Save tons of money whilst improving the outcomes, lowers insurance costs due to better outcomes, reduced exposure to lawsuits, reduced hospital costs, patient satisfaction, etc. Next thing you know, the phone is ringing for Keith and Kelly.
You don't have to remind me of the guesswork inherent in this post. I get it. I also get the Actipatch PEMF tech, KT Tape (smart, aggressive marketing; recent signing of tennis #1 ranked player Sofia Kenin; the Olympics), DJO, unannounced SAI, Allay, migraine studies, the ever elusive Dr. Scholl's and probably a whole lot more I'm not mentioning. Something very mysterious happening at the FDA with another possible OEM and/or licensing? I know, FDA and mysterious in the same sentence, will wonders ever cease?
Bright future, lots of positive energy.
Remember to eat your vegetables, kids - WBeacham
4
